Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 16

Results For "India"

3079 News Found

Glenmark launches next phase of ‘India First Heart First’ campaign
Healthcare | May 17, 2024

Glenmark launches next phase of ‘India First Heart First’ campaign

35,000 doctors from across India pledged their support for the initiative to raise awareness about cardiovascular diseases


Takeda appoints Annapurna Das as the General Manager, India Operations
People | May 17, 2024

Takeda appoints Annapurna Das as the General Manager, India Operations

Annapurna will lead the company in India ensuring patient access to its highly innovative medicines and vaccines


Cresset opens new new India HQ in Bengaluru to tap potential of APAC market
News | May 17, 2024

Cresset opens new new India HQ in Bengaluru to tap potential of APAC market

Cresset’s new India site will support the growing demands of Cresset’s APAC customer base


Granules India posts Q4 FY24 consolidated PAT at Rs. 129.64 Cr
News | May 16, 2024

Granules India posts Q4 FY24 consolidated PAT at Rs. 129.64 Cr

The company has posted net profit of Rs. 405.31 crores for the Financial Year ended March 31, 2024


Sanofi India posts Q1 CY24 PAT at Rs. 136.6 Cr
News | May 14, 2024

Sanofi India posts Q1 CY24 PAT at Rs. 136.6 Cr

Sanofi India has reported total income of Rs. 738.9 crores during the period ended March 31, 2024


Novartis India posts Q4 FY24 net profit lower at Rs. 14.68 Cr
News | May 12, 2024

Novartis India posts Q4 FY24 net profit lower at Rs. 14.68 Cr

Novartis India has reported total income of Rs. 91.59 crores during the period ended March 31, 2024


OMRON Healthcare India and AliveCor partner to improve heart healthcare in India
Healthcare | May 11, 2024

OMRON Healthcare India and AliveCor partner to improve heart healthcare in India

These devices instantly detect various arrhythmias, including atrial fibrillation (Afib), bradycardia, tachycardia, and more


Abbott India posts Q4 FY24 PAT at Rs. 287.06 Cr
News | May 10, 2024

Abbott India posts Q4 FY24 PAT at Rs. 287.06 Cr

The company has posted net profit of Rs. 1,201.22 crores for the Financial Year ended March 31, 2024


Dabur India posts Q4 FY24 consolidated PAT at Rs. 349.53 Cr
News | May 04, 2024

Dabur India posts Q4 FY24 consolidated PAT at Rs. 349.53 Cr

The company has reported total income of Rs. 2,943.49 crores during the period ended March 31, 2024


Granules India announced ANDA Approval for Colchicine Capsules
Drug Approval | May 01, 2024

Granules India announced ANDA Approval for Colchicine Capsules

Colchicine Capsules are indicated for prophylaxis of gout flares in adult